Q3 2023 Earnings Estimate for Catalent, Inc. Issued By KeyCorp (NYSE:CTLT)
Q3 2023 Earnings Estimate for Catalent, Inc. Issued By KeyCorp (NYSE:CTLT)
Catalent, Inc. (NYSE:CTLT – Get Rating) – Equities research analysts at KeyCorp dropped their Q3 2023 earnings estimates for Catalent in a report issued on Sunday, December 18th. KeyCorp analyst P. Knight now anticipates that the company will earn $0.79 per share for the quarter, down from their prior estimate of $0.95. KeyCorp has a "Overweight" rating and a $85.00 price objective on the stock. The consensus estimate for Catalent's current full-year earnings is $3.05 per share.
Catalent，Inc.(纽约证券交易所代码：CTLT-GET Rating)-在12月18日周日发布的一份报告中，KeyCorp的股票研究分析师下调了对Catalent 2023年第三季度收益的预期。KeyCorp分析师P·奈特现在预计，该公司本季度每股收益将为0.79美元，低于此前预期的0.95美元。KeyCorp对该股的评级为“增持”，目标价为85.00美元。对Catalent目前全年收益的普遍预期为每股3.05美元。
A number of other equities analysts have also weighed in on the stock. Jefferies Financial Group dropped their target price on shares of Catalent from $130.00 to $110.00 and set a "buy" rating for the company in a research report on Tuesday, August 30th. Royal Bank of Canada lowered their price objective on shares of Catalent from $125.00 to $73.00 and set an "outperform" rating for the company in a research report on Wednesday, November 2nd. StockNews.com lowered shares of Catalent from a "hold" rating to a "sell" rating in a research report on Saturday, November 5th. Morgan Stanley lowered their price objective on shares of Catalent from $120.00 to $81.00 and set an "overweight" rating for the company in a research report on Thursday, November 3rd. Finally, Argus lowered shares of Catalent from a "buy" rating to a "hold" rating in a research report on Monday, November 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $92.80.
其他一些股票分析师也加入了该股的行列。杰富瑞金融集团在8月30日(星期二)的一份研究报告中将卡特伦特股票的目标价从130.00美元下调至110.00美元，并对该公司设定了“买入”评级。11月2日，加拿大皇家银行在一份研究报告中将卡特伦特股票的目标价从125.00美元下调至73美元，并为该公司设定了“跑赢大盘”的评级。在11月5日星期六的一份研究报告中，StockNews.com将Catalent的股票评级从持有下调至卖出。11月3日周四，摩根士丹利在一份研究报告中将卡特伦特股票的目标价从120.00美元下调至81美元，并对该公司设定了“增持”评级。最后，Argus在11月7日星期一的一份研究报告中将Catalent的股票评级从“买入”下调至“持有”。一位股票研究分析师将该股的评级定为卖出，三位分析师给出了持有评级，五位分析师给出了买入评级。根据MarketBeat.com的数据，该股目前的平均评级为持有，共识目标价为92.80美元。
Catalent Price Performance
催化剂的性价比
Catalent (NYSE:CTLT – Get Rating) last posted its quarterly earnings results on Tuesday, November 1st. The company reported $0.25 earnings per share for the quarter, missing analysts' consensus estimates of $0.49 by ($0.24). The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.06 billion. Catalent had a return on equity of 12.55% and a net margin of 8.83%.
Catalent(NYSE：CTLT-GET Rating)最近一次公布季度收益是在11月1日星期二。该公司公布本季度每股收益为0.25美元，低于分析师普遍预期的0.49美元(0.24美元)。该公司本季度营收为10.2亿美元，而市场普遍预期为10.6亿美元。Catalent的股本回报率为12.55%，净利润率为8.83%。
Insider Buying and Selling at Catalent
Catalent的内幕买卖
In other news, insider Thomas W. Hawkeswood sold 930 shares of Catalent stock in a transaction that occurred on Monday, October 10th. The shares were sold at an average price of $77.46, for a total value of $72,037.80. Following the transaction, the insider now owns 5,364 shares of the company's stock, valued at approximately $415,495.44. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Catalent news, insider Thomas W. Hawkeswood sold 930 shares of Catalent stock in a transaction on Monday, October 10th. The shares were sold at an average price of $77.46, for a total value of $72,037.80. Following the transaction, the insider now directly owns 5,364 shares of the company's stock, valued at $415,495.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Michael J. Grippo sold 2,451 shares of Catalent stock in a transaction on Monday, October 31st. The stock was sold at an average price of $65.83, for a total transaction of $161,349.33. Following the completion of the transaction, the senior vice president now directly owns 17,792 shares in the company, valued at $1,171,247.36. The disclosure for this sale can be found here. In the last quarter, insiders have sold 4,161 shares of company stock valued at $273,713. Company insiders own 0.58% of the company's stock.
在其他消息方面，内部人士托马斯·W·霍克斯伍德在10月10日星期一的一笔交易中出售了930股Catalent股票。这些股票的平均价格为77.46美元，总价值为72,037.80美元。交易完成后，这位内部人士现在拥有5364股该公司股票，价值约415,495.44美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的，该文件可以通过这个环节。在加泰罗尼亚的其他消息中，内部人士托马斯·W·霍克斯伍德在10月10日星期一的一笔交易中出售了930股加泰罗尼亚股票。这些股票的平均价格为77.46美元，总价值为72,037.80美元。交易完成后，这位内部人士现在直接持有5364股该公司股票，价值415,495.44美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的，该文件可通过美国证券交易委员会网站。此外，高级副总裁迈克尔·J·格里波在10月31日(星期一)的一笔交易中出售了2451股Catalent股票。该股以65.83美元的平均价格出售，总成交金额为161,349.33美元。交易完成后，高级副总裁现在直接拥有该公司17,792股，价值1,171,247.36美元。关于这次销售的披露可以找到这里。在上个季度，内部人士出售了4,161股公司股票，价值273,713美元。公司内部人士持有该公司0.58%的股份。
Institutional Investors Weigh In On Catalent
机构投资者看好Catalent
A number of large investors have recently made changes to their positions in CTLT. Price T Rowe Associates Inc. MD raised its position in shares of Catalent by 9.9% in the second quarter. Price T Rowe Associates Inc. MD now owns 22,303,561 shares of the company's stock worth $2,392,949,000 after acquiring an additional 2,011,520 shares during the period. Artisan Partners Limited Partnership raised its position in shares of Catalent by 20.4% during the 2nd quarter. Artisan Partners Limited Partnership now owns 5,232,772 shares of the company's stock worth $561,424,000 after purchasing an additional 887,520 shares during the last quarter. BlackRock Inc. raised its position in shares of Catalent by 5.2% during the 3rd quarter. BlackRock Inc. now owns 16,086,469 shares of the company's stock worth $1,164,016,000 after purchasing an additional 792,923 shares during the last quarter. Viking Global Investors LP raised its position in shares of Catalent by 66.2% during the 1st quarter. Viking Global Investors LP now owns 1,893,644 shares of the company's stock worth $210,005,000 after purchasing an additional 754,290 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its position in shares of Catalent by 17.7% during the 1st quarter. JPMorgan Chase & Co. now owns 4,474,419 shares of the company's stock worth $496,212,000 after purchasing an additional 673,706 shares during the last quarter. 90.54% of the stock is owned by hedge funds and other institutional investors.
一些大型投资者最近改变了他们在CTLT的头寸。Price T Rowe Associates Inc.MD在第二季度将其在Catalent股票的持仓提高了9.9%。Price T Rowe Associates Inc.MD现在拥有22,303,561股该公司股票，价值2,392,949,000美元，在此期间又购买了2,011,520股。Artisan Partners Limited Partnership在第二季度将其在Catalent的股票头寸增加了20.4%。Artisan Partners Limited Partnership现在拥有该公司5232,772股股票，价值561,424,000美元，上个季度又购买了887,520股。贝莱德股份有限公司在第三季度将其在Catalent的持股比例提高了5.2%。贝莱德股份有限公司在上个季度增持了792,923股后，目前持有该公司16,086,469股股票，价值1,164,016,000美元。Viking Global Investors LP在第一季度将其在Catalent股票的持仓增加了66.2%。Viking Global Investors LP在上个季度额外购买了754,290股后，现在拥有1,893,644股该公司股票，价值210,005,000美元。最后，摩根大通在第一季度将其持有的Catalent股票头寸提高了17.7%。摩根大通在上个季度增持了673,706股，目前持有4,474,419股该公司股票，价值496,211,000美元。90.54%的股票由对冲基金和其他机构投资者持有。
About Catalent
关于Catalent
(Get Rating)
(获取评级)
Catalent, Inc, together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations.
Catalent公司及其子公司在全球范围内开发和制造药物、基于蛋白质的生物制剂、细胞和基因疗法以及消费者保健产品的解决方案。软凝胶和口腔技术部门提供用于一系列客户产品的软胶囊的配方、开发和制造服务，如处方药、非处方药、膳食补充剂、单位剂量化妆品和动物保健药物制剂。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Catalent (CTLT)
- Is There a Prize in Store for Kellogg Shareholders?
- Will AMC's Troubles Affect Its Landlord, EPR Properties?
- General Mills Retreats To More Attractive Territory
- Will Tesla Shares Rally If Musk Steps Down From Twitter?
- 5 Down But Not Out Stocks To Watch For 2023
- 免费获取StockNews.com关于Catalent的研究报告(CTLT)
- 凯洛格的股东有店内奖品吗？
- AMC的麻烦会影响其房东EPR Properties吗？
- 通用磨坊撤退至更具吸引力的地区
- 如果马斯克退出Twitter，特斯拉的股价会上涨吗？
- 2023年值得关注的5个下跌但不是下跌的股票
Receive News & Ratings for Catalent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Catalent Daily》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Catalent和相关公司的最新新闻和分析师评级的每日简要摘要。